Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Pharma-Bio Serv Inc. (PBSV) had Return on Tangible Equity of 0.07% for the most recently reported fiscal quarter, ending 2025-01-31.
| Income Statement Financials | |
$2.47M |
|
$0.01M |
|
$1.70M |
|
$0.77M |
|
$2.56M |
|
$-0.09M |
|
$0.10M |
|
$0.01M |
|
$0.01M |
|
$0.01M |
|
$0.01M |
|
$0.01M |
|
$0.01M |
|
$-0.09M |
|
$-0.04M |
|
22.96M |
|
22.96M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$15.53M |
|
$0.16M |
|
$0.54M |
|
$16.08M |
|
$3.42M |
|
-- |
|
$0.66M |
|
$4.08M |
|
$12.00M |
|
$12.00M |
|
$12.00M |
|
22.96M |
|
| Cash Flow Statement Financials | |
$-0.43M |
|
$0.99M |
|
-- |
|
$6.77M |
|
$7.31M |
|
$0.54M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
31.08% |
|
-3.73% |
|
-3.73% |
|
-- |
|
0.39% |
|
0.35% |
|
$-0.43M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
-- |
|
0.92 |
|
97.66 |
|
0.07% |
|
|
Return on Tangible Equity |
0.07% |
0.05% |
|
0.07% |
|
$0.52 |
|
$-0.02 |
|
$-0.02 |
|